Pyrexia, commonly referred to as fever, is a frequent symptom encountered in clinical practice. It is an increase in body temperature as a response to pathogenic invasion or inflammation. Understanding the underlying mechanisms and effective management strategies is crucial for healthcare professionals.
Pyrexia is primarily triggered by pyrogens, which can be either exogenous, such as bacterial toxins, or endogenous, like cytokines. These substances instigate the hypothalamus to elevate the body's thermoregulatory set-point, leading to fever. It is a defense mechanism, aiming to create an unfavorable environment for pathogens.
A comprehensive history and physical examination form the cornerstone of assessing a febrile patient. The duration, pattern, and associated symptoms of fever can provide valuable clues to the underlying cause. Laboratory tests and imaging studies can be utilized based on clinical suspicion.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used. Care should be taken with the elderly, infants, and immunocompromised patients, as fever can have deleterious effects in these populations.
While antipyretics are effective in reducing discomfort, their use should be judicious. Fever is a physiological response and its suppression may potentially hamper the body's defense mechanism. Therefore, the decision to use antipyretics should be individualized, considering the patient's condition and comfort.
Pyrexia is a common clinical presentation with a wide array of underlying causes. A thorough understanding of its pathophysiology, assessment, and management strategies is essential for optimal patient care. While antipyretics provide symptomatic relief, their use should be balanced with the potential impact on the body's defense mechanisms.
1.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
2.
Childhood cancer survivors face new health problems later in life, study shows
3.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
1.
Obesity is a major risk factor for cancer
2.
Prevention of Thrombotic Complications in High-Risk Patients
3.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
4.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Hands-on Workshop: Hematology
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation